WuXi XDC Cayman, Inc. (HK:2268) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
WuXi XDC Cayman Inc. has announced a further delay in sending out the Circular to shareholders, which includes details of the Antibodies Master Services Agreement and the Revised Annual Caps related to it. The Circular, initially expected by September 30, 2024, will now be dispatched by October 11, 2024, due to the need for additional time to prepare certain information. This postponement follows previous delays communicated by the company in August and September 2024.
For further insights into HK:2268 stock, check out TipRanks’ Stock Analysis page.